-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2024.
- Integrated Biopharma Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $490K.
- Integrated Biopharma Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $795K, a 2108% increase year-over-year.
- Integrated Biopharma Inc annual Operating Income (Loss) for 2024 was $251K, a 109% increase from 2023.
- Integrated Biopharma Inc annual Operating Income (Loss) for 2023 was $120K, a 95.6% decline from 2022.
- Integrated Biopharma Inc annual Operating Income (Loss) for 2022 was $2.75M, a 52.5% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)